The effects of dietary immunostimulants on the innate immune response of Indian major carp: A review.

Immunostimulants, as feed additives, play an important role in maintaining fish health and enhancing their overall growth by providing resistance against diseases in cultured fish. At the initial stages of life of fish, innate immunity is the essential mechanism in their survival. Later, innate immunity has an instructive role in adapting acquired immune response and homeostasis through different receptor proteins. Several studies have been conducted to analyze the effect of dietary immunostimulants like algae, plant extracts, vitamins, herbs, probiotics, and prebiotics-containing diets in Indian major carps. Many bacterial, fungal and viral pathogens are responsible for high death rates in both wild and cultured fish. It's a major limiting factor for world aquaculture industries. Recognition of invading pathogens by different pathogen recognition receptor plays an important role for the activation of different pathways to initiate protective immune responses. Hence, there is a growing need to control the devastating effects of diseases without recourse to toxic chemicals or antibiotics. Keeping with alternative approaches without using toxic chemicals to control fish diseases in mind, many immunostimulants are used, which enhance immune responses along with their gene expression level through different signaling pathway. The objective of this review is to summarize and evaluate the current knowledge of various immunostimulants and their immune responses in three Indian major carps namely Catla catla, Labeo rohita and Cirrhinus mrigala, which are preferred by the people.

Novel PVA/chitosan composite membrane modified using bio-fabricated α-MnO2 nanoparticles for photocatalytic degradation of cationic dyes.

By integrating the benefits of poly vinyl alcohol (PVA) and chitosan (CS) with α-MnO2 nanoparticles (MNPs), a novel type of nano-polymer composite (PVA/CS-MNP) membrane was synthesized through a simple and facile casting method. In this proposed work, the membrane prepared was used for removal of organic textile dyes from their aqueous solutions. The as-synthesized PVA/CS-MNP membrane was examined using different analytical techniques such as Fourier transform infrared spectroscopy (FTIR) and field emission scanning electron microscopy (FESEM), and mechanical properties of material was also studied. Two cationic dyes, methylene blue (MB) and eosin yellow (EY), were chosen as template dyes to be removed from industrial waste water. These dyes were degraded by carrying out a reaction in which the synthesized membrane was used as a photocatalyst. The study of kinetics revealed that the reaction process followed pseudo-first-order kinetics. The efficiency of catalyst and the rate of reaction were also examined by varying parameters such as pH, initial concentration of dyes, and composition of membrane. The maximum efficiency of catalyst was observed at pH 12 as more than 95% of dyes degraded within 1 h of time span. The catalyst was found to be reusable as its efficiency did not deteriorate even after using it for several times. Such functional membrane having higher stability, low production cost, excellent efficiency to degrade dyes, and good recyclability are promising material for distinctly effective deletion of organic dyes from waste water.

Application of α-MnO2 nanoparticles for residual oil mobilization through surfactant polymer flooding.

Injection of surfactant and polymer slug is among the most effective chemical enhanced oil recovery processes. The only problem encountered with the surfactant polymer (SP) flooding is the loss of surface-active agents that reduce the efficiency of surfactants in the chemical slug. Various attempts to modify SP flooding have been made previously so that the surfactant loss due to adsorption could be reduced. Nanoparticles (NPs) are one of the most effective ways of reducing surfactant adsorption as surfactant particles are held in the liquid phase by nanoparticles, resulting in lower surfactant losses due to adsorption. However, the high cost of the NPs limits their use on the field scale. To encounter this problem, the present study focuses on the application of the manganese dioxide NPs, synthesized through a green route that is economically viable. These NPs are found to be cost-effective as compared to commercially available NPs as well as the synthesis of these NPs does not require the use of toxic chemicals. The 1000 ppm NPs effectively reduced the surfactant adsorption by 46%. The surface tension was lowered from 29.4 to 26.1 mN/m when 1000 ppm NPs were applied to 2500 ppm surfactant solution. Also, the nanoparticles were found to increase the viscosity of the chemical slug by increasing the solid particles present in the slug. The sand pack flooding experiments were carried out to assess the crude oil mobilization ability of the NPs assisted SP flooding. The oil recovery was found to increase from 5% of the original oil in place, resulting in ~ 75% of the crude oil recovery, which was only ~ 70% when NPs were not introduced into the system.

Cost-Effectiveness Analysis of Omalizumab for Severe Allergic Asthma in Japan Using Real-World Evidence.

OBJECTIVES: Omalizumab is a recommended add-on therapy for patients with severe allergic asthma who remain uncontrolled despite treatment with standard of care (SoC). This study evaluated the cost-effectiveness of omalizumab compared with SoC applying real-world clinical outcomes in adult patients with severe allergic asthma in Japan. METHODS: A validated Markov model was adapted for Japan and compared the cost-effectiveness of omalizumab as an add-on therapy to SoC versus SoC alone using the most recently updated price of omalizumab. A Japanese real-world postmarketing surveillance and a pivotal randomized clinical trial were used as inputs for clinical effectiveness. Japanese life tables and literature were accessed for mortality data and unit costs were extracted from a Japanese insurance claims database. Quality of life data were retrieved from the clinical trial. RESULTS: In the base case, the incremental cost-effectiveness ratio for omalizumab add-on therapy was ¥2.85 million per quality-adjusted life-year gained (approximately €21 000; 1€ = ¥133.26) compared with SoC alone. The model appeared to be most sensitive to changes in clinically significant severe exacerbation fatality, day-to-day asthma symptom utilities for SoC, discount rates for benefits, day-to-day asthma symptom utilities for omalizumab responders, time horizon, and the annual cost of omalizumab. The results of the probabilistic sensitivity analysis showed that the probability of omalizumab being cost-effective was 93% to 98% at a threshold of ¥5 to ¥6 million (willingness-to-pay for 1 quality-adjusted life-year). CONCLUSIONS: Omalizumab add-on therapy is cost-effective compared with SoC alone in Japan in severe allergic asthma population who are uncontrolled with high-dose inhaled corticosteroid and other controllers.

Impact of choice of inhalers for asthma care on global carbon footprint and societal costs: a long-term economic evaluation.

BACKGROUND: While effective asthma control medications reduce the burden of asthma, a significant subgroup of these treatments, namely metered-dose inhalers (MDIs), produce substantial greenhouse gas (GHG) emissions, thus contributing to climate change. This study quantified the global climate impact (i.e. carbon dioxide equivalent [CO2e] emissions) and costs of long-term status quo asthma inhaler use versus alternative scenarios substituting MDIs with propellant-free dry powder inhalers (DPIs). METHODS: Three scenarios were evaluated across 10-year (2020-2030) and 50-year (2020-2070) time horizons: A (status quo inhaler use), B and C (2% and 5% year-over-year substitution of MDIs with DPIs, respectively). Global inhaler volumes and costs at baseline were sourced from IQVIA, then projected using UN and WHO trends in per capita GDP, urbanization, and asthma population growth. Inhaler spending was assumed to fall by 90% following generic entry in 2030. The carbon footprint per inhaler and health damage factors for disability-adjusted life years (DALYs) were derived from literature. The US government's central and high-impact estimates for the social cost of carbon (SCC) were used to calculate emissions costs. RESULTS: Over 50 years, scenario A resulted in 826 million tonnes of CO2e emissions globally, with an associated SCC between 21% and 65% of the projected global spending on asthma inhalers. In comparison, CO2e emissions were reduced by 38% and 58% in Scenarios B and C, respectively, and DALYs improved by 33 and 51%. Depending on SCC estimates, Scenarios B and C increased global costs by 7.3% and 16.5%, respectively (central SCC), or decreased costs by 4.2% and 2.6% (high-impact SCC) versus Scenario A. Over 10 years, Scenario A resulted in 97 million tonnes of CO2e emissions globally, with an associated SCC between 4.4% and 12.2% of projected spending. In comparison, Scenarios B and C were associated with 12% and 24% reductions in CO2e emissions and improvements in DALYs by 11.5% and 22.7%, respectively. CONCLUSIONS: Global efforts by environmental and health-policy decision-makers to substitute currently available MDIs with DPIs for asthma control would result in substantial reductions in GHG emissions with manageable costs, or potential cost savings, depending on the SCC. Policies that decrease use of MDIs warrant global attention.

Carbon footprint and associated costs of asthma exacerbation care among UK adults.

INTRODUCTION: Asthma exacerbations are a primary driver of costs and health impacts from asthma. Despite research suggesting that asthma care has a disproportionate carbon footprint, emissions costs are not considered when evaluating its societal burden. To advance the understanding of greenhouse gas (GHG) emissions associated with asthma, we estimated the carbon footprint and associated costs of asthma exacerbation care by severity level among UK adults. METHODS: Guidelines for asthma exacerbation treatment in UK adults were reviewed by severity level: mild, moderate, and severe/life-threatening. Components of care for each severity were evaluated for GHG emission potential and key drivers were identified. Carbon dioxide equivalent (CO2e) emissions of drivers were sourced from published literature and combined to estimate the carbon footprint per exacerbation, by severity level. Emissions were scaled up to the annual UK adult population based on the annual number of exacerbations at each severity. Costs associated with emissions were estimated using the UK government's 2020 nontraded price of carbon, at £71 per tonne CO2e (tCO2e). RESULTS: Overall, emissions drivers for exacerbations were medical services, including patient-travel, and quick-relief inhalers. The annual number of mild, moderate, and severe/life-threatening asthma exacerbations among UK adults were 118.9 M, 5.5 M, and 2.4 M. Associated annual carbon footprints were estimated to be 83,455 tCO2e, 192,709 tCO2e, and 448,037 tCO2e for mild, moderate, and severe/life-threatening exacerbations, respectively, with a total of 724,201 tCO2e. Total annual emissions costs from exacerbation care were £51.3 M; £5.9 M, £13.6 M, and £31.7 M for mild, moderate, and severe/life-threatening exacerbations, respectively. CONCLUSION: GHG emissions from asthma exacerbation management were the highest for severe/life-threatening events, followed by moderate exacerbations. Treatment to reduce the severity and occurrence of exacerbations, such as effective, long-term control therapy via lower-emission dry powder inhalers (DPIs), can help mitigate asthma care emissions. For mild exacerbations, the use of DPIs can eliminate associated emissions.

Study of adsorption of anionic dyes over biofabricated crystalline α-MnO2 nanoparticles.

The leaf extract of Ficus retusa plant was used for fabrication of α-MnO2 nanoparticles (NPs). The extract was utilized as a reducing agent for green synthesis of nanomaterial. The synthesis of nanocrystals was confirmed using different analytical techniques such as field emission scanning electron microscopy (FESEM), energy-dispersive X-ray (EDX) spectroscopy, X-ray diffraction (XRD) spectroscopy and thermogravimetric analysis (TGA). The synthesis of NPs was studied over a wide range of temperatures from 80 to 800 °C. It was found that perfectly crystalline α-MnO2 NPs were successfully synthesized at 800 °C. The synthesized NPs were applied as an adsorbent for adsorption of azo dyes such as methyl red (MR) and methyl orange (MO) which are released as wastes from industries into water bodies and pollute the water. The removal efficiency was analysed and optimized depending on various parameters like pH, concentration of NPs, and contact time. The experimental data was explained by three isotherm models, viz. Langmuir, Freundlich and Temkin isotherms. Kinetic and thermodynamic studies of adsorption were also carried out, which depicted that the adsorption process of both dyes was exothermic in nature and followed pseudo-second-order kinetics. The results confirmed that NPs are easily fabricated through a green route and prove to be an excellent adsorbent for the removal of MO and MR dyes from their aqueous solutions. The maximum adsorption capacity of NPs synthesized was found to be 116.1 mg g-1 and 74.02 mg g-1 for MO and MR dyes, respectively. Graphical abstract.